NCT05212961 is a clinical trial in Mucormycosis, sponsored by Minia University.

Who is sponsoring NCT05212961?

NCT05212961 is sponsored by Minia University.

What condition does NCT05212961 study?

NCT05212961 studies Mucormycosis.

Is NCT05212961 still recruiting?

NCT05212961 is currently completed. Last updated 18 October 2023.

Last reviewed 2023-10-18 · How we verify

NCT05212961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 and Rhino-orbital Mucormycosis

Completed Last updated 18 October 2023

What this trial tests

trial in Mucormycosis in 40 participants. Completed in 28 September 2023.

Timeline

28 December 2021

Primary endpoint
28 June 2023

28 September 2023

Quick facts

Lead sponsor	Minia University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	28 December 2021
Primary completion	28 June 2023
Estimated completion	28 September 2023
Sites	1 location across Egypt

Conditions studied

Mucormycosis — all drugs for Mucormycosis →

Sponsor

Minia University

Who can join

Eligibility, any sex, with Mucormycosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mucormycosis

Currently open trials in the same condition.

NCT07191756 — Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study · active not recruiting
NCT06440915 — Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children · NA · recruiting
NCT06515743 — Rehabilitation With an Obturator in Maxillary Defects · active not recruiting

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05212961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 18 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05212961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing